Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study

BACKGROUND: Patients with solid or hematological tumors or neurological and immune-inflammatory disorders are potentially fragile subjects at increased risk of experiencing severe coronavirus disease 2019 and an inadequate response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Corradini, Paolo, Agrati, Chiara, Apolone, Giovanni, Mantovani, Alberto, Giannarelli, Diana, Marasco, Vincenzo, Bordoni, Veronica, Sacchi, Alessandra, Matusali, Giulia, Salvarani, Carlo, Zinzani, Pier Luigi, Mantegazza, Renato, Tagliavini, Fabrizio, Lupo-Stanghellini, Maria Teresa, Ciceri, Fabio, Damian, Silvia, Uccelli, Antonio, Fenoglio, Daniela, Silvestris, Nicola, Baldanti, Fausto, Piaggio, Giulia, Ciliberto, Gennaro, Morrone, Aldo, Locatelli, Franco, Sinno, Valentina, Rescigno, Maria, Costantini, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213871/
https://www.ncbi.nlm.nih.gov/pubmed/35607769
http://dx.doi.org/10.1093/cid/ciac404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213871/
https://www.ncbi.nlm.nih.gov/pubmed/35607769
http://dx.doi.org/10.1093/cid/ciac404

Ejemplares similares